New vaccines for a safer world: The Coalition for Epidemic Preparedness and Innovations

About This Source - acmedsci

The Academy of Medical Sciences (Acmedsci) is an independent body in the UK representing the diversity of medical science. Their mission is to advance biomedical and health research and its translation into benefits for society.

Recent from acmedsci:

  • AMS – Addressing the Challenges of Anaemia in the Andean Region
  • PhD strategies during COVID-19 | Jessica Dobson
  • Coping with COVID-19 PhD stress | Emma Taylor
  • CEPI was established with the vision of a world in which epidemics are no longer a threat to humanity.
    Dr Mike Whelan talks how and why CEPI was established, the partnerships involved and how CEPI will achieve its objective to develop vaccines for emerging pathogens with the potential to cause epidemics. CEPI’s initial priority pathogens include MERS, Lassa, NIPAH, Chikungunya and Rift Valley fever.

    Mike is a Biochemist and Immunologist, graduating from The Royal London Hospital in 1993. He carried out post-doctoral research at the Institute for Animal Health and the Edward Jenner Institute for Vaccine Research.
    In 1999, Mike joined Onyvax Ltd., based in St. George’s Hospital, as Head of Immunology. The company was developing allogeneic whole cell vaccines for prostate cancer, carrying out both Phase I and II clinical trials. Mike became Head of Research in 2003. He then joined iQur in 2006 and became Director of R&D, working on the development of a novel virus like particle vaccine delivery system. He held several vaccine development research grants working on universal influenza, malaria, hepatitis and Burkholderia.
    Mike joined CEPI in December 2017 and is a Programme Manager currently working on a wide portfolio of neglected disease vaccines including Lassa, Nipah and MERS. His portfolio also includes the development of novel technologies which could be applied to Pathogen X. Mike is an Honorary Lecturer at the Royal Veterinary College.

    Read more about the Academy’s work to stop superbugs through international collaboration:

    This talk was given as part of the Hamied Foundation UK-India Antimicrobial Resistance Meetings. Find out more about the meetings:

    The Academy is strengthening research links between the UK and India through Hamied Foundation UK-India AMR Visiting Professorships. Find out more:

    We are the independent body in the UK representing the diversity of medical science. Our mission is to advance biomedical and health research and its translation into benefits for society.

    Find the Academy of Medical Sciences online:

    In This Story: India

    India, officially the Republic of India, is a country in South Asia. It is the second-most populous country, the seventh-largest country by land area, and the most populous democracy in the world. New Delhi is the capital.

    It has an exceptionally diverse population, with Hindus, Muslims, Christians, Sikhs, Buddhists, Jains and other religions speaking over 21 recognised languages.

    2 Recent Items: India

  • Biden Warns Delta Variant Could Hurt Under-Vaccinated Areas of U.S.
  • LIVE: President Biden speaks on Covid-19 response and vaccination program — 6/18/21
  • In This Story: Malaria

    Malaria is a mosquito-borne infectious disease that affects humans and other animals. Malaria causes symptoms that typically include fever, tiredness, vomiting, and headaches.

    2 Recent Items: Malaria

  • Babesiosis: What you should know about the tick-borne illnesses on the rise
  • Thousands still displaced after DR Congo volcanic eruption
  • Leave a Comment